Systematic review with meta‐analysis
Systematic review with meta‐analysis: the efficacy and safety of CT‐P13, a biosimilar of anti‐tumour necrosis factor‐α agent (infliximab), in inflammatory bowel diseases.
Influence of food and lifestyle
Influence of food and lifestyle on the risk of developing inflammatory bowel disease.
Inflammatory bowel disease in pregnancy
Inflammatory bowel disease in pregnancy: a population‐based study of prevalence and pregnancy outcomes.